Corient Private Wealth LP Invests $50.01 Million in CVS Health Corporation $CVS

Corient Private Wealth LP purchased a new stake in CVS Health Corporation (NYSE:CVS) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 644,830 shares of the pharmacy operator’s stock, valued at approximately $50,011,000. Corient Private Wealth LP owned about 0.05% of CVS Health as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CVS. BlackRock Inc. bought a new position in shares of CVS Health in the second quarter worth about $12,747,462,000. State Street Corp grew its stake in shares of CVS Health by 2.1% during the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after purchasing an additional 1,245,457 shares during the last quarter. Capital International Investors increased its holdings in shares of CVS Health by 3.4% in the fourth quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock valued at $2,189,793,000 after purchasing an additional 900,153 shares in the last quarter. Bank of America Corp DE raised its position in CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after purchasing an additional 13,836,701 shares during the last quarter. Finally, Norges Bank acquired a new position in CVS Health during the 4th quarter worth $1,666,265,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Wall Street Zen raised CVS Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. Robert W. Baird set a $107.00 price target on CVS Health in a research note on Thursday, August 6th. Barclays lifted their price objective on CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Piper Sandler reissued an “overweight” rating on shares of CVS Health in a report on Wednesday. Finally, Cantor Fitzgerald raised their target price on shares of CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, July 7th. Twenty-two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Stock Down 1.5%

NYSE:CVS opened at $92.88 on Friday. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The stock’s fifty day simple moving average is $101.52 and its 200-day simple moving average is $89.43. The firm has a market capitalization of $118.79 billion, a P/E ratio of 24.57, a P/E/G ratio of 0.86 and a beta of 0.61.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter in the prior year, the company posted $1.81 earnings per share. The firm’s revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is currently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.